The result showed patients with high B7-H4 and IDO1 expression in brain metastases had a shorter survival time (log-rank test), and B7-H4 was an independent prognostic factor in lung adenocarcinoma brain metastases patients. This evidence concerns the gene IDO1 and lung adenocarcinoma.